$ULBI
ULTRALIFE CORP

2018 Q3 Form 10-Q Financial Statement

#000143774918014224 Filed on August 02, 2018

View on sec.gov

Income Statement

Concept 2018 Q3 2017 Q4 2017 Q3
Revenue $20.33M $21.05M $19.94M
YoY Change 1.96% -2.7% 1.57%
Cost Of Revenue $14.29M $14.79M $13.72M
YoY Change 4.16% -0.19% 0.62%
Gross Profit $6.041M $6.255M $6.221M
YoY Change -2.89% -8.15% 3.74%
Gross Profit Margin 29.71% 29.72% 31.2%
Selling, General & Admin $3.442M $3.637M $3.714M
YoY Change -7.32% 1.03% 6.05%
% of Gross Profit 56.98% 58.15% 59.7%
Research & Development $1.099M $1.355M $1.185M
YoY Change -7.26% -7.19% -12.68%
% of Gross Profit 18.19% 21.66% 19.05%
Depreciation & Amortization $496.0K $497.0K $507.0K
YoY Change -2.17% -19.84% -4.88%
% of Gross Profit 8.21% 7.95% 8.15%
Operating Expenses $4.541M $4.992M $4.899M
YoY Change -7.31% -3.26% 0.82%
Operating Profit $1.500M $1.263M $1.322M
YoY Change 13.46% -23.45% 16.17%
Interest Expense -$20.00K -$40.00K -$40.00K
YoY Change -50.0% -20.0% -20.0%
% of Operating Profit -1.33% -3.17% -3.03%
Other Income/Expense, Net $21.00K -$20.00K -$8.000K
YoY Change -362.5% -166.67% -140.0%
Pretax Income $1.521M $1.205M $1.273M
YoY Change 19.48% -26.07% 14.89%
Income Tax $86.00K $104.0K $179.0K
% Of Pretax Income 5.65% 8.63% 14.06%
Net Earnings $1.408M $1.098M $1.094M
YoY Change 28.7% -37.26% 7.36%
Net Earnings / Revenue 6.93% 5.22% 5.49%
Basic Earnings Per Share $0.09 $0.07 $0.07
Diluted Earnings Per Share $0.09 $0.07 $0.07
COMMON SHARES
Basic Shares Outstanding 15.95M 15.56K 15.51K
Diluted Shares Outstanding 16.52M 15.97K 15.85K

Balance Sheet

Concept 2018 Q3 2017 Q4 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.30M $14.60M $14.90M
YoY Change 36.24% 37.74% 122.39%
Cash & Equivalents $25.01M $18.24M $14.93M
Short-Term Investments
Other Short-Term Assets $2.900M $2.600M $1.800M
YoY Change 61.11% 18.18% -35.71%
Inventory $23.12M $26.33M $24.49M
Prepaid Expenses
Receivables $14.53M $14.66M $13.54M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $66.01M $61.92M $54.80M
YoY Change 20.44% 25.29% 16.14%
LONG-TERM ASSETS
Property, Plant & Equipment $8.792M $7.570M $7.833M
YoY Change 12.24% -5.36% -8.4%
Goodwill $20.20M $20.46M $20.22M
YoY Change -0.11% 2.47% -0.2%
Intangibles $7.167M $7.169M
YoY Change -0.38%
Long-Term Investments
YoY Change
Other Assets $96.00K $125.0K $143.0K
YoY Change -32.87% 73.61% 95.89%
Total Long-Term Assets $35.79M $35.27M $35.46M
YoY Change 0.93% -0.15% -2.49%
TOTAL ASSETS
Total Short-Term Assets $66.01M $61.92M $54.80M
Total Long-Term Assets $35.79M $35.27M $35.46M
Total Assets $101.8M $97.19M $90.27M
YoY Change 12.77% 14.68% 8.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.260M $8.787M $7.647M
YoY Change -5.06% 20.5% 20.94%
Accrued Expenses $4.100M $5.700M $3.800M
YoY Change 7.89% 46.15% -24.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $12.36M $14.24M $11.87M
YoY Change 4.13% 25.7% 3.47%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $32.00K $31.00K $27.00K
YoY Change 18.52% 72.22% -3.57%
Total Long-Term Liabilities $32.00K $31.00K $27.00K
YoY Change 18.52% 72.22% -3.57%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.36M $14.24M $11.87M
Total Long-Term Liabilities $32.00K $31.00K $27.00K
Total Liabilities $16.30M $18.14M $17.52M
YoY Change -6.94% 7.42% 3.01%
SHAREHOLDERS EQUITY
Retained Earnings -$77.71M -$82.89M -$87.79M
YoY Change -11.49% -8.45% -4.87%
Common Stock $1.996M $1.966M $1.957M
YoY Change 1.99% 1.76% 1.66%
Preferred Stock
YoY Change
Treasury Stock (at cost) $18.47M $18.47M
YoY Change
Treasury Stock Shares $4.020M $4.020M $4.016M
Shareholders Equity $85.59M $79.20M $72.91M
YoY Change
Total Liabilities & Shareholders Equity $101.8M $97.19M $90.27M
YoY Change 12.77% 14.68% 8.03%

Cashflow Statement

Concept 2018 Q3 2017 Q4 2017 Q3
OPERATING ACTIVITIES
Net Income $1.408M $1.098M $1.094M
YoY Change 28.7% -37.26% 7.36%
Depreciation, Depletion And Amortization $496.0K $497.0K $507.0K
YoY Change -2.17% -19.84% -4.88%
Cash From Operating Activities $2.740M -$370.0K $1.290M
YoY Change 112.4% -109.07% -70.48%
INVESTING ACTIVITIES
Capital Expenditures -$830.0K -$130.0K -$260.0K
YoY Change 219.23% -43.48% 160.0%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$830.0K -$130.0K -$260.0K
YoY Change 219.23% -55.17% 550.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 750.0K 130.0K 250.0K
YoY Change 200.0% -48.0% -134.25%
NET CHANGE
Cash From Operating Activities 2.740M -370.0K 1.290M
Cash From Investing Activities -830.0K -130.0K -260.0K
Cash From Financing Activities 750.0K 130.0K 250.0K
Net Change In Cash 2.660M -370.0K 1.280M
YoY Change 107.81% -109.16% -64.44%
FREE CASH FLOW
Cash From Operating Activities $2.740M -$370.0K $1.290M
Capital Expenditures -$830.0K -$130.0K -$260.0K
Free Cash Flow $3.570M -$240.0K $1.550M
YoY Change 130.32% -105.57% -65.32%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q3 ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount
1268286
CY2017Q3 ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount
1055097
ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount
1254286
ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount
1055097
CY2018Q3 ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount Restricted Stock
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmountRestrictedStock
17500
CY2017Q3 ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount Restricted Stock
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmountRestrictedStock
13400
ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount Restricted Stock
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmountRestrictedStock
17500
ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount Restricted Stock
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmountRestrictedStock
13400
CY2018Q3 ulbi Interest And Other Finance Costs
InterestAndOtherFinanceCosts
-86000
CY2017Q3 ulbi Interest And Other Finance Costs
InterestAndOtherFinanceCosts
49000
ulbi Interest And Other Finance Costs
InterestAndOtherFinanceCosts
48000
ulbi Interest And Other Finance Costs
InterestAndOtherFinanceCosts
142000
ulbi Proceeds From Government Subsidies
ProceedsFromGovernmentSubsidies
CY2018Q3 ulbi Revenue Total Percentage
RevenueTotalPercentage
ulbi Revenue Total Percentage
RevenueTotalPercentage
CY2018Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
6656000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
33000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8787000
CY2018Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15468000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14657000
CY2018Q3 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
140000
CY2017Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
168000
CY2018Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
60054000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
203000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
209000
CY2018Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
101000
CY2017Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
104000
CY2018Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
401750
CY2017Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1060916
CY2017Q3 ulbi Revenue Total Percentage
RevenueTotalPercentage
ulbi Revenue Total Percentage
RevenueTotalPercentage
ulbi Proceeds From Government Subsidies
ProceedsFromGovernmentSubsidies
397000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
59141000
CY2018Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2036000
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1611000
CY2018Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
181818000
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
180211000
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
205000
CY2017Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
356000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
344000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
396000
CY2018Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
283000
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
292000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
18000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
415750
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1060916
CY2018Q3 us-gaap Assets
Assets
98845000
CY2017Q4 us-gaap Assets
Assets
97186000
CY2018Q3 us-gaap Assets Current
AssetsCurrent
63523000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
61916000
CY2018Q3 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2017Q3 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
6000
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
28000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10629000
CY2017Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14933000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2419000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4304000
CY2018Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19961404
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19670928
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15941693
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15651217
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
1996000
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
1966000
CY2018Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
450000
CY2017Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1588000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3352000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3502000
CY2018Q3 us-gaap Cash
Cash
20285000
CY2017Q4 us-gaap Cash
Cash
18241000
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20285000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18241000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20749000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18330000
CY2018Q3 us-gaap Cost Of Revenue
CostOfRevenue
16314000
CY2017Q3 us-gaap Cost Of Revenue
CostOfRevenue
13718000
us-gaap Cost Of Revenue
CostOfRevenue
32101000
us-gaap Cost Of Revenue
CostOfRevenue
28863000
CY2018Q3 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
57000
CY2017Q3 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
130000
CY2017Q3 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
3000
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
8000
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
8000
us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
89000
us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
151000
CY2018Q3 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
4000
CY2018Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
17000
CY2017Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
40000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
36000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
79000
CY2018Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
32000
CY2017Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
32000
CY2018Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
3891000
CY2017Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
3867000
CY2018Q3 us-gaap Depreciation
Depreciation
496000
CY2017Q3 us-gaap Depreciation
Depreciation
507000
us-gaap Depreciation
Depreciation
980000
us-gaap Depreciation
Depreciation
1010000
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.23
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-90000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
123000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.034
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.088
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2018Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1711000
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2413000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y146D
CY2018Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
91000
CY2018Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
844000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
0
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
0
CY2018Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9440000
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9259000
us-gaap Finite Lived Intangible Assets Foreign Currency Translation Gain Loss
FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
-99000
CY2018Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
16245000
CY2017Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
16344000
CY2018Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6805000
CY2017Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7085000
CY2016Q4 us-gaap Goodwill
Goodwill
19965000
CY2017Q3 us-gaap Goodwill
Goodwill
20223000
CY2017Q4 us-gaap Goodwill
Goodwill
20458000
CY2018Q3 us-gaap Goodwill
Goodwill
20322000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
258000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
235000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-136000
CY2018Q3 us-gaap Gross Profit
GrossProfit
6550000
CY2017Q3 us-gaap Gross Profit
GrossProfit
6221000
us-gaap Gross Profit
GrossProfit
13832000
us-gaap Gross Profit
GrossProfit
13111000
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1718000
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1273000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3940000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3021000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3940000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3021000
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
78000
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
179000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
133000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
266000
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-4177000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
6000
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
478000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
872000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
274000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-36000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-79000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1338000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
904000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-141000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-246000
CY2018Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
598061
CY2017Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
339705
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
540836
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
291062
CY2018Q3 us-gaap Interest And Debt Expense
InterestAndDebtExpense
21000
CY2017Q3 us-gaap Interest And Debt Expense
InterestAndDebtExpense
41000
us-gaap Interest And Debt Expense
InterestAndDebtExpense
54000
us-gaap Interest And Debt Expense
InterestAndDebtExpense
109000
CY2018Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
8785000
CY2017Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
9707000
CY2018Q3 us-gaap Inventory Net
InventoryNet
24861000
CY2017Q4 us-gaap Inventory Net
InventoryNet
26326000
CY2018Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
13739000
CY2017Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
14606000
CY2018Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2337000
CY2017Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2013000
CY2018Q3 us-gaap Liabilities
Liabilities
14777000
CY2017Q4 us-gaap Liabilities
Liabilities
18137000
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
98845000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
97186000
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
10854000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14239000
CY2018Q3 us-gaap Minority Interest
MinorityInterest
-124000
CY2017Q4 us-gaap Minority Interest
MinorityInterest
-154000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1690000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
989000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-999000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-836000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1818000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4028000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
1627000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
1094000
us-gaap Net Income Loss
NetIncomeLoss
3777000
us-gaap Net Income Loss
NetIncomeLoss
2749000
CY2018Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
13000
CY2017Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
30000
CY2018Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
107000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1632000
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1322000
us-gaap Operating Income Loss
OperatingIncomeLoss
3988000
us-gaap Operating Income Loss
OperatingIncomeLoss
3163000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
4918000
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
4899000
us-gaap Operating Expenses
OperatingExpenses
9844000
us-gaap Operating Expenses
OperatingExpenses
9948000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
125000
CY2018Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1177000
CY2017Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
494000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-425000
CY2017Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
149000
CY2016Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
172000
CY2018Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
151000
CY2017Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
163000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
753000
CY2018Q3 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
6805000
CY2017Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
7085000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
5000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
38000
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
7000
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
29000
us-gaap Profit Loss
ProfitLoss
3807000
us-gaap Profit Loss
ProfitLoss
2755000
CY2018Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2347000
CY2017Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2871000
CY2018Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
32000
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
31000
CY2018Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
107000
CY2017Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-33000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
999000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
836000
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2018Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2445000
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2603000
CY2018Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
354000
CY2017Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
248000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1293000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
989000
CY2018Q3 us-gaap Profit Loss
ProfitLoss
1640000
CY2017Q3 us-gaap Profit Loss
ProfitLoss
1094000
CY2018Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
68110000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
66711000
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8056000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7570000
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1218000
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1185000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2318000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2323000
CY2018Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
464000
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
89000
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-79117000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-82894000
CY2018Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
22864000
CY2017Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
19939000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
45933000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
41974000
CY2018Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3700000
CY2017Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3714000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7526000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7625000
us-gaap Share Based Compensation
ShareBasedCompensation
344000
us-gaap Share Based Compensation
ShareBasedCompensation
396000
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.16
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.47
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.026
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
981556
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
116199
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
216500
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.22
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5886000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1860211
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1670036
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.10
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.45
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
4648000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
6.43
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
5584000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1563589
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.56
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
11.53
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
9.68
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y7D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y313D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P3Y262D
CY2018Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
4.86
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
290476
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
84192000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
79203000
CY2018Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
84068000
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
79049000
CY2018Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
4019711
CY2018Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
598
CY2017Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
340
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
541
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
291
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16520
CY2017Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15850
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16354
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15752
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15922
CY2017Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15510
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15813
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15461
CY2017Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
4019711
CY2018Q3 us-gaap Treasury Stock Value
TreasuryStockValue
18469000
CY2017Q4 us-gaap Treasury Stock Value
TreasuryStockValue
18469000
CY2018Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0

Files In Submission

Name View Source Status
0001437749-18-014224-index-headers.html Edgar Link pending
0001437749-18-014224-index.html Edgar Link pending
0001437749-18-014224.txt Edgar Link pending
0001437749-18-014224-xbrl.zip Edgar Link pending
ex_118805.htm Edgar Link pending
ex_118806.htm Edgar Link pending
ex_118807.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ulbi-20180701.xml Edgar Link completed
ulbi-20180701.xsd Edgar Link pending
ulbi-20180701_cal.xml Edgar Link unprocessable
ulbi-20180701_def.xml Edgar Link unprocessable
ulbi-20180701_lab.xml Edgar Link unprocessable
ulbi-20180701_pre.xml Edgar Link unprocessable
ulbi20180623_10q.htm Edgar Link pending
ulbi20180623_10qimg001.jpg Edgar Link pending